Member Info for daft63

From the start, I got out and still am. We all know that the product and Carl's team are top notch, but I suspect we are looking at other machinations in play here, its pointless being emotional about business. Someone is selling and thats usually because they have 1. Lost Faith 2. Have reason to believe they can get back in cheaper. I am expecting news within 24hrs, look at Chamberlin rns, expecting to be trading within this week. The 2 may be related or not but it seems a coincidence. Try and keep it friendly, I'm just observing.

Well folks I'm out, its been a good share for me and I believe in the product and Prof Carl. But can't help but feel that TB is not as committed as he could be, its not just his sales last week which were 30% of his holding, but the total lack of any PR. I say again, its been a great ride and I wish you all the very best.

My 3rd post today, because I won't get a chance with all the newly converted and the non believers due to arrive, last night some avct pusher got in a ding dong on twitter with Prof Carl, it was a sign of crap to come. If you believed in your decision up to now, then you should be feeling good right now, I won't be selling any of mine anytime soon so will leave the BB to the newbies. The SP will do what it does, no guessing from me, and nobody can predict what or when news may drop, forget the SP, concentrate on the value of what the Sheffield team have devoted months of brainstorming on, realise the lives, time and money it may save, try putting a value on the extra months it may offer to someone. The varied uses of this system may mean it has a direct influence on your loved ones in the coming years, feel good about having invested in something worthwhile rather than the usual rape and pillage investments we have all been involved with, and when we are all reaping the rewards, devote some time to Prof Carl and the team, Nobel contenders. Enjoy!

Alzhiemers: 50m globally, 10m new cases p.a. Sepsis: 49m cases p.a. Bladder Cancer 550k cases p.a.

What value on exclusive rights on each or all, add on the Covid, plus ability to adapt for any new breakouts with ease. We have no need to manufacture a single unit. Each of the above would generate the owners vast returns over the next decade, add in the fact that early diagnosis saves lives and money, allowing tailored care regimes specific to results.

Covid, Alzhiemers, Sepsis, Bladder Cancer and more, each one of which is worth tens of millions per year. Fridays news doesn't just derisk, it makes us massively undervalued. It also makes us a serious threat to many bigger valued rivals, we are an investment group, 38m shares, Mcap £44m ish. Don't be surprised if we don't own Paraytec in 8 weeks time, or next week. Don't be surprised if TB drops more news at times that are inconvenient to traders, he did it Friday, and will enjoy doing it again. Enjoy the ride, don't be fooled by MMs games or BB idiots, getting frozen out is a real risk to anyone who thinks they can play this, anything can happen here. If you read my crap, then congratulations you deserve a reward.atb

It would be very prudent to maintain a very tight hold, no saying where this goes next! Well done to the regulars, have a fantastic weekend all.

In an alternate universe, we are still in Europe, hospitals are full whilst unelected to$$ers dictate to millions, each arguing that their better than their neighbours, vaccines lay unused in fridges ,whilst domestically Jeremy sadly passed leaving Professor Diane to lead us forward. Boris's book 'My Lucky Escape' tops the charts. Let's leave the politics off the bb!

Patience is all that's required here, don't get stressed about daily moves up or down, maybe use the dips to increase positions if suitable. We are 5 weeks from approval of a testing process that offers speed, sensitivity and flexibility across a broad spectrum of applications, Alzhiemers, Covid, Sepsis and potentially many more, with ability to detect future pandemics by aptamer adjustments, and matrix technology all thrown in. Only 38m shares available and many of them held tight. Just give it time and await the facts. Atb.

The only question that needs to be asked : Is this worth more than its currently valued at?

It would be ignoring the facts to not observe that the traders have played this well, the turning point on Thursday was determined by the same point 10 trading days previous, and proved true, not always the case, but with low volumes and no news it was a easy play for some. For any share to grow traders are an essential component, they attract interest, as the interest grows it attracts investments from those who may not have been looking in this particular direction. It is clear that brh has some spare shares in the float, and until they find stickier mitts, will be part of our path forward. Factual news will change the formula, and if that news drops suddenly it makes trading more difficult but not impossible. As for where we go, who knows, if Monday brings volume and we break the £1 then new highs could well be reached, as we know the test works well, a fact in place since last highs were reached. Facts change the value and attract stable holders, the float narrows and volatility subdues but until then anything can happen.

The MMs working in association with the gambling department again, it won't do to lose money.

Topping up time.

Thats a quality system, but only 40 samples tested, there's room for competition, its amazing how far diagnotics can propel itself when money and brains get chucked at it, it makes you wonder what else would benefit from the same attention. When apps and companies can generate huge Mcaps from making peoples life easier and lazier, more should be thrown at those problems that deeply impact real life issues.

First past the post is not going to be the long term investment, that will go to the best performer, speed, accuracy and precision will win out in the long run, if we produce a testing platform that has functionality across a spectrum of applications from a singular device then its appeal will be attractive globally. Its easy to forsee a Swiss precision device certified by a global pharma being used for multiplex testing and adaptations, with updates for newly developed functions. But by then the cash will be in our accounts as a distant memory.

DaP, you are thinking wrong, we are not going to be like your other covid shares, its an investment group not bloody primark. All we need to do to dramatically increase our Mcap is introduce the products, the details you request are for others to formulate.

I'm not sure we sell Paraytec, unless a really serious offer is made, much better to monetise each aspect of its technology under licence, I don't think we will manufacture ever, rather utilise others to do so. But an all encompassing buyout would generate huge benefits for both brh and any potential bidder. With diverse functionality the income potential long term makes this much less of a Covid reliant stock, whilst still being a contender.

Right now, the team are fine tuning to eliminate false readings, it believes that it will be able to confirm, within a period of 4 weeks, from 01/03, a market leading value!
If that drops, the SP won't!!

Look its simple, nobody knows what the SP may do, people will always try to guess and estimate but thats all it is. As for the test, everyone is putting way too much focus on Covid and 1st past the post, and those in the running have it priced in, look at the Mcap rises, but the best tests will win long term, and testing is a long term necessity, the 1st may not endure, but be superceded by others. The Mcap here is abysmal for what and where its at, the alternatives that our test offers, and the proven expertise behind it. In a couple of weeks time, more will be known but remember that we are an investment group, and have no need to manufacture, Prof Carl will work with whoever funds the numerous spin off projects developing from this technology, and we will ensure that the best price is achieved for anything we put to market. The funds available to snap up potentially radical diagnostic technologies are limitless, so guess all you want, but thats all it is. Anything can happen.

No matter what crap gets posted here, for or against, the truth is we have a working test system that may be very fast, sensitive and whose adaptability may be applicable across a broad spectrum of uses. If you are investing here, at this point, the Mcap of £23m should be attractive because the upsides outweigh any potential downside, there is little risk of this not leading to an eventual return of income in some form. What you need to decide is do you get in now, at a discounted cost due to risks involved,or do you await CE approval in maybe 2 months time or less. That depends on your own investment strategy, time moves fast, but approval will ensure a much inflated price, beyond that who knows, but the money generating abilities of the test system in the long term seem reasonable if not fantastic,the Non Covid side reduces any need for speed. If everything was guaranteed then we wouldn't be at this price, but waiting till its a risk free certainty may also mean its too late, be sure that approval will equal a big "for sale" sign sitting in Paraytecs window, if not a Sold sign.

Well if this is my last post due to censorship, good luck with your investments all, long live free speech.atb